Use_of_combined_exogenous_gonadotropins_and_pulsatile_gonadotropin-releasing_hormone_in_patients_with_polycystic_ovarian_disease_published_erratum_appears_in_Fertil_Steril_1991_Jun;55(6):1213_We_previously_tested_a_combined_regimen_based_on_the_administration_of_gonadotropin_in_the_early_follicular_phase_followed_by_pulsatile_gonadotropin-releasing_hormone_(GnRH)_until_complete_follicular_maturation_in_patients_suffering_from_polycystic_ovarian_disease._Despite_good_clinical_results,_a_high_rate_of_premature_luteinization_was_observed_with_this_approach._We_therefore_evaluated_in_this_study_whether_starting_pulsatile_GnRH_therapy_before_gonadotropin_administration_might_reduce_premature_luteinization._Eight_women_underwent_induction_of_ovulation_with_both_combined_therapy_and_pure_exogenous_follicle-stimulating_hormone_alone_using_a_crossover_scheme._No_premature_luteinization_and_a_single_follicular_growth_were_recorded_with_the_modified_combined_regimen._Clinical_results_(8/8_versus_3/7_ovulatory_cycles;_3/8_versus_1/7_pregnancies)_favor_the_combined_approach_over_gonadotropin_alone.